Global Proteomics Market is projected to reach USD 56.9 billion by 2027 from USD 26.8 billion in 2021, at a CAGR of 16.9% during the forecast period. Proteomics is the study of proteome which is a set of proteins present in the cell. Proteomes are different from one cell to another cell with requirements, stress, different time, and the organism.Proteomics help in the functioning and structure of the proteins used in the diagnosis, treatment, and drug discovery of various diseases. Moreover, proteomics also helps in the evaluation of protein production rate, the interaction between the proteins, protein modification, and involvement in the metabolic pathways. Proteomics needs various equipment, instruments, media, reagents, and, software for the identification, quantification, and interactions between the proteins.Increase in demand for personalized medicine, technological advancements for identification, increase in R&D activities by public and private sectors and rise in the prevalence of genetic disorders expected to boost the proteomics market over the forecast period.+ Rise in the number of biopharmaceutical and pharmaceutical companies, growing healthcare expenditure, and increasing innovations in the genomics field expected to propel the proteomics market. However, stringent regulatory policies, lack of professionals for R&D activities, and a high cost of the devices and drugs might dampen the proteomics market revenue growth over the forecast period.